Table of Contents for the Digital Edition of Drug Information Journal - November 2008 Drug Information Journal - November 2008 Contents An Investigation of Proportion Designs Based on a Molecularly Targeted Endpoint The Importance of Medical Innovation in an Investigator’s Decision to Take Part in Clinical Trials Confirm and Explore: A Stepwise Approach to Clinical Study Designs Publishing a Drug Information Bulletin: Experiences From a Developing Country Opening the Black Box of Pharmaceutical Patent Value: An Empirical Analysis Legal Requirements for Drug Information Resources Maintained by Pharmacies A Comparative Study of the Communication of Drug Safety Information by Governmental Agencies in Japan and Western Countries: The Case of Asthma Medications Accounting for Interim Analyses in the Assessment of Program Expected Net Present Value A Noninferiority Margin for Acne Lesion Counts Statistical Test for Ordered Categorical Data in Clinical Trials How Biased Are Indirect Comparisons, Particularly When Comparisons Are Made Over Time in Controlled Trials? A Review of Pharmacoepidemiology and Therapeutic Risk Management Author Index to Volume 42, 2008 Key Word Index to Volume 42, 2008 Drug Information Journal - November 2008 Drug Information Journal - November 2008 - Contents (Page Cover1) Drug Information Journal - November 2008 - Contents (Page Cover2) Drug Information Journal - November 2008 - Contents (Page 513) Drug Information Journal - November 2008 - Contents (Page 514) Drug Information Journal - November 2008 - Contents (Page 515) Drug Information Journal - November 2008 - Contents (Page 516) Drug Information Journal - November 2008 - Contents (Page 517) Drug Information Journal - November 2008 - Contents (Page 518) Drug Information Journal - November 2008 - Contents (Page 519) Drug Information Journal - November 2008 - Contents (Page 520) Drug Information Journal - November 2008 - Contents (Page 521) Drug Information Journal - November 2008 - Contents (Page 522) Drug Information Journal - November 2008 - Contents (Page 523) Drug Information Journal - November 2008 - Contents (Page 524) Drug Information Journal - November 2008 - Contents (Page 525) Drug Information Journal - November 2008 - Contents (Page 526) Drug Information Journal - November 2008 - An Investigation of Proportion Designs Based on a Molecularly Targeted Endpoint (Page 527) Drug Information Journal - November 2008 - An Investigation of Proportion Designs Based on a Molecularly Targeted Endpoint (Page 528) Drug Information Journal - November 2008 - An Investigation of Proportion Designs Based on a Molecularly Targeted Endpoint (Page 529) Drug Information Journal - November 2008 - An Investigation of Proportion Designs Based on a Molecularly Targeted Endpoint (Page 530) Drug Information Journal - November 2008 - An Investigation of Proportion Designs Based on a Molecularly Targeted Endpoint (Page 531) Drug Information Journal - November 2008 - An Investigation of Proportion Designs Based on a Molecularly Targeted Endpoint (Page 532) Drug Information Journal - November 2008 - An Investigation of Proportion Designs Based on a Molecularly Targeted Endpoint (Page 533) Drug Information Journal - November 2008 - An Investigation of Proportion Designs Based on a Molecularly Targeted Endpoint (Page 534) Drug Information Journal - November 2008 - An Investigation of Proportion Designs Based on a Molecularly Targeted Endpoint (Page 535) Drug Information Journal - November 2008 - An Investigation of Proportion Designs Based on a Molecularly Targeted Endpoint (Page 536) Drug Information Journal - November 2008 - The Importance of Medical Innovation in an Investigator’s Decision to Take Part in Clinical Trials (Page 537) Drug Information Journal - November 2008 - The Importance of Medical Innovation in an Investigator’s Decision to Take Part in Clinical Trials (Page 538) Drug Information Journal - November 2008 - The Importance of Medical Innovation in an Investigator’s Decision to Take Part in Clinical Trials (Page 539) Drug Information Journal - November 2008 - The Importance of Medical Innovation in an Investigator’s Decision to Take Part in Clinical Trials (Page 540) Drug Information Journal - November 2008 - The Importance of Medical Innovation in an Investigator’s Decision to Take Part in Clinical Trials (Page 541) Drug Information Journal - November 2008 - The Importance of Medical Innovation in an Investigator’s Decision to Take Part in Clinical Trials (Page 542) Drug Information Journal - November 2008 - The Importance of Medical Innovation in an Investigator’s Decision to Take Part in Clinical Trials (Page 543) Drug Information Journal - November 2008 - The Importance of Medical Innovation in an Investigator’s Decision to Take Part in Clinical Trials (Page 544) Drug Information Journal - November 2008 - Confirm and Explore: A Stepwise Approach to Clinical Study Designs (Page 545) Drug Information Journal - November 2008 - Confirm and Explore: A Stepwise Approach to Clinical Study Designs (Page 546) Drug Information Journal - November 2008 - Confirm and Explore: A Stepwise Approach to Clinical Study Designs (Page 547) Drug Information Journal - November 2008 - Confirm and Explore: A Stepwise Approach to Clinical Study Designs (Page 548) Drug Information Journal - November 2008 - Confirm and Explore: A Stepwise Approach to Clinical Study Designs (Page 549) Drug Information Journal - November 2008 - Confirm and Explore: A Stepwise Approach to Clinical Study Designs (Page 550) Drug Information Journal - November 2008 - Confirm and Explore: A Stepwise Approach to Clinical Study Designs (Page 551) Drug Information Journal - November 2008 - Confirm and Explore: A Stepwise Approach to Clinical Study Designs (Page 552) Drug Information Journal - November 2008 - Confirm and Explore: A Stepwise Approach to Clinical Study Designs (Page 553) Drug Information Journal - November 2008 - Confirm and Explore: A Stepwise Approach to Clinical Study Designs (Page 554) Drug Information Journal - November 2008 - Publishing a Drug Information Bulletin: Experiences From a Developing Country (Page 555) Drug Information Journal - November 2008 - Publishing a Drug Information Bulletin: Experiences From a Developing Country (Page 556) Drug Information Journal - November 2008 - Publishing a Drug Information Bulletin: Experiences From a Developing Country (Page 557) Drug Information Journal - November 2008 - Publishing a Drug Information Bulletin: Experiences From a Developing Country (Page 558) Drug Information Journal - November 2008 - Publishing a Drug Information Bulletin: Experiences From a Developing Country (Page 559) Drug Information Journal - November 2008 - Publishing a Drug Information Bulletin: Experiences From a Developing Country (Page 560) Drug Information Journal - November 2008 - Opening the Black Box of Pharmaceutical Patent Value: An Empirical Analysis (Page 561) Drug Information Journal - November 2008 - Opening the Black Box of Pharmaceutical Patent Value: An Empirical Analysis (Page 562) Drug Information Journal - November 2008 - Opening the Black Box of Pharmaceutical Patent Value: An Empirical Analysis (Page 563) Drug Information Journal - November 2008 - Opening the Black Box of Pharmaceutical Patent Value: An Empirical Analysis (Page 564) Drug Information Journal - November 2008 - Opening the Black Box of Pharmaceutical Patent Value: An Empirical Analysis (Page 565) Drug Information Journal - November 2008 - Opening the Black Box of Pharmaceutical Patent Value: An Empirical Analysis (Page 566) Drug Information Journal - November 2008 - Opening the Black Box of Pharmaceutical Patent Value: An Empirical Analysis (Page 567) Drug Information Journal - November 2008 - Opening the Black Box of Pharmaceutical Patent Value: An Empirical Analysis (Page 568) Drug Information Journal - November 2008 - Legal Requirements for Drug Information Resources Maintained by Pharmacies (Page 569) Drug Information Journal - November 2008 - Legal Requirements for Drug Information Resources Maintained by Pharmacies (Page 570) Drug Information Journal - November 2008 - Legal Requirements for Drug Information Resources Maintained by Pharmacies (Page 571) Drug Information Journal - November 2008 - Legal Requirements for Drug Information Resources Maintained by Pharmacies (Page 572) Drug Information Journal - November 2008 - Legal Requirements for Drug Information Resources Maintained by Pharmacies (Page 573) Drug Information Journal - November 2008 - Legal Requirements for Drug Information Resources Maintained by Pharmacies (Page 574) Drug Information Journal - November 2008 - Legal Requirements for Drug Information Resources Maintained by Pharmacies (Page 575) Drug Information Journal - November 2008 - Legal Requirements for Drug Information Resources Maintained by Pharmacies (Page 576) Drug Information Journal - November 2008 - Legal Requirements for Drug Information Resources Maintained by Pharmacies (Page 577) Drug Information Journal - November 2008 - Legal Requirements for Drug Information Resources Maintained by Pharmacies (Page 578) Drug Information Journal - November 2008 - Legal Requirements for Drug Information Resources Maintained by Pharmacies (Page 579) Drug Information Journal - November 2008 - Legal Requirements for Drug Information Resources Maintained by Pharmacies (Page 580) Drug Information Journal - November 2008 - Legal Requirements for Drug Information Resources Maintained by Pharmacies (Page 581) Drug Information Journal - November 2008 - Legal Requirements for Drug Information Resources Maintained by Pharmacies (Page 582) Drug Information Journal - November 2008 - A Comparative Study of the Communication of Drug Safety Information by Governmental Agencies in Japan and Western Countries: The Case of Asthma Medications (Page 583) Drug Information Journal - November 2008 - A Comparative Study of the Communication of Drug Safety Information by Governmental Agencies in Japan and Western Countries: The Case of Asthma Medications (Page 584) Drug Information Journal - November 2008 - A Comparative Study of the Communication of Drug Safety Information by Governmental Agencies in Japan and Western Countries: The Case of Asthma Medications (Page 585) Drug Information Journal - November 2008 - A Comparative Study of the Communication of Drug Safety Information by Governmental Agencies in Japan and Western Countries: The Case of Asthma Medications (Page 586) Drug Information Journal - November 2008 - A Comparative Study of the Communication of Drug Safety Information by Governmental Agencies in Japan and Western Countries: The Case of Asthma Medications (Page 587) Drug Information Journal - November 2008 - A Comparative Study of the Communication of Drug Safety Information by Governmental Agencies in Japan and Western Countries: The Case of Asthma Medications (Page 588) Drug Information Journal - November 2008 - A Comparative Study of the Communication of Drug Safety Information by Governmental Agencies in Japan and Western Countries: The Case of Asthma Medications (Page 589) Drug Information Journal - November 2008 - A Comparative Study of the Communication of Drug Safety Information by Governmental Agencies in Japan and Western Countries: The Case of Asthma Medications (Page 590) Drug Information Journal - November 2008 - A Comparative Study of the Communication of Drug Safety Information by Governmental Agencies in Japan and Western Countries: The Case of Asthma Medications (Page 591) Drug Information Journal - November 2008 - A Comparative Study of the Communication of Drug Safety Information by Governmental Agencies in Japan and Western Countries: The Case of Asthma Medications (Page 592) Drug Information Journal - November 2008 - A Comparative Study of the Communication of Drug Safety Information by Governmental Agencies in Japan and Western Countries: The Case of Asthma Medications (Page 593) Drug Information Journal - November 2008 - A Comparative Study of the Communication of Drug Safety Information by Governmental Agencies in Japan and Western Countries: The Case of Asthma Medications (Page 594) Drug Information Journal - November 2008 - A Comparative Study of the Communication of Drug Safety Information by Governmental Agencies in Japan and Western Countries: The Case of Asthma Medications (Page 595) Drug Information Journal - November 2008 - A Comparative Study of the Communication of Drug Safety Information by Governmental Agencies in Japan and Western Countries: The Case of Asthma Medications (Page 596) Drug Information Journal - November 2008 - Accounting for Interim Analyses in the Assessment of Program Expected Net Present Value (Page 597) Drug Information Journal - November 2008 - Accounting for Interim Analyses in the Assessment of Program Expected Net Present Value (Page 598) Drug Information Journal - November 2008 - Accounting for Interim Analyses in the Assessment of Program Expected Net Present Value (Page 599) Drug Information Journal - November 2008 - Accounting for Interim Analyses in the Assessment of Program Expected Net Present Value (Page 600) Drug Information Journal - November 2008 - Accounting for Interim Analyses in the Assessment of Program Expected Net Present Value (Page 601) Drug Information Journal - November 2008 - Accounting for Interim Analyses in the Assessment of Program Expected Net Present Value (Page 602) Drug Information Journal - November 2008 - Accounting for Interim Analyses in the Assessment of Program Expected Net Present Value (Page 603) Drug Information Journal - November 2008 - Accounting for Interim Analyses in the Assessment of Program Expected Net Present Value (Page 604) Drug Information Journal - November 2008 - Accounting for Interim Analyses in the Assessment of Program Expected Net Present Value (Page 605) Drug Information Journal - November 2008 - Accounting for Interim Analyses in the Assessment of Program Expected Net Present Value (Page 606) Drug Information Journal - November 2008 - A Noninferiority Margin for Acne Lesion Counts (Page 607) Drug Information Journal - November 2008 - A Noninferiority Margin for Acne Lesion Counts (Page 608) Drug Information Journal - November 2008 - A Noninferiority Margin for Acne Lesion Counts (Page 609) Drug Information Journal - November 2008 - A Noninferiority Margin for Acne Lesion Counts (Page 610) Drug Information Journal - November 2008 - A Noninferiority Margin for Acne Lesion Counts (Page 611) Drug Information Journal - November 2008 - A Noninferiority Margin for Acne Lesion Counts (Page 612) Drug Information Journal - November 2008 - A Noninferiority Margin for Acne Lesion Counts (Page 613) Drug Information Journal - November 2008 - A Noninferiority Margin for Acne Lesion Counts (Page 614) Drug Information Journal - November 2008 - A Noninferiority Margin for Acne Lesion Counts (Page 615) Drug Information Journal - November 2008 - A Noninferiority Margin for Acne Lesion Counts (Page 616) Drug Information Journal - November 2008 - Statistical Test for Ordered Categorical Data in Clinical Trials (Page 617) Drug Information Journal - November 2008 - Statistical Test for Ordered Categorical Data in Clinical Trials (Page 618) Drug Information Journal - November 2008 - Statistical Test for Ordered Categorical Data in Clinical Trials (Page 619) Drug Information Journal - November 2008 - Statistical Test for Ordered Categorical Data in Clinical Trials (Page 620) Drug Information Journal - November 2008 - Statistical Test for Ordered Categorical Data in Clinical Trials (Page 621) Drug Information Journal - November 2008 - Statistical Test for Ordered Categorical Data in Clinical Trials (Page 622) Drug Information Journal - November 2008 - Statistical Test for Ordered Categorical Data in Clinical Trials (Page 623) Drug Information Journal - November 2008 - Statistical Test for Ordered Categorical Data in Clinical Trials (Page 624) Drug Information Journal - November 2008 - How Biased Are Indirect Comparisons, Particularly When Comparisons Are Made Over Time in Controlled Trials? (Page 625) Drug Information Journal - November 2008 - How Biased Are Indirect Comparisons, Particularly When Comparisons Are Made Over Time in Controlled Trials? (Page 626) Drug Information Journal - November 2008 - How Biased Are Indirect Comparisons, Particularly When Comparisons Are Made Over Time in Controlled Trials? (Page 627) Drug Information Journal - November 2008 - How Biased Are Indirect Comparisons, Particularly When Comparisons Are Made Over Time in Controlled Trials? (Page 628) Drug Information Journal - November 2008 - How Biased Are Indirect Comparisons, Particularly When Comparisons Are Made Over Time in Controlled Trials? (Page 629) Drug Information Journal - November 2008 - How Biased Are Indirect Comparisons, Particularly When Comparisons Are Made Over Time in Controlled Trials? (Page 630) Drug Information Journal - November 2008 - How Biased Are Indirect Comparisons, Particularly When Comparisons Are Made Over Time in Controlled Trials? (Page 631) Drug Information Journal - November 2008 - How Biased Are Indirect Comparisons, Particularly When Comparisons Are Made Over Time in Controlled Trials? (Page 632) Drug Information Journal - November 2008 - How Biased Are Indirect Comparisons, Particularly When Comparisons Are Made Over Time in Controlled Trials? (Page 633) Drug Information Journal - November 2008 - How Biased Are Indirect Comparisons, Particularly When Comparisons Are Made Over Time in Controlled Trials? (Page 634) Drug Information Journal - November 2008 - A Review of Pharmacoepidemiology and Therapeutic Risk Management (Page 635) Drug Information Journal - November 2008 - A Review of Pharmacoepidemiology and Therapeutic Risk Management (Page 636) Drug Information Journal - November 2008 - Author Index to Volume 42, 2008 (Page 637) Drug Information Journal - November 2008 - Author Index to Volume 42, 2008 (Page 638) Drug Information Journal - November 2008 - Key Word Index to Volume 42, 2008 (Page 639) Drug Information Journal - November 2008 - Key Word Index to Volume 42, 2008 (Page 640) Drug Information Journal - November 2008 - Key Word Index to Volume 42, 2008 (Page Cover3) Drug Information Journal - November 2008 - Key Word Index to Volume 42, 2008 (Page Cover4) http://www.nxtbook.com/nxtbooks/dia/druginformationjournal1110 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0910 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0710 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0510 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0310 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0110 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal1109 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0909 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0709 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0509 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0309 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0109 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal1108 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0908 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0708 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0508 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0308 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0108 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal1107 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0907 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0707 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0507 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0307 http://www.nxtbookMEDIA.com
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.